KD Logo

UBS analysts initates a Buy rating for Kura Oncology Inc (KURA)

Kura Oncology Inc’s filing revealed that its Chief Operating Officer FORD KATHLEEN unloaded Company’s shares for reported $8434.0 on Nov 18 ’24. In the deal valued at $16.03 per share,526 shares were sold. As a result of this transaction, FORD KATHLEEN now holds 23,184 shares worth roughly $0.37 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, FORD KATHLEEN bought 526 shares, generating $8,410 in total proceeds.

Before that, Bair Teresa Brophy sold 2,615 shares. Kura Oncology Inc shares valued at $57,916 were divested by the Chief Legal Officer at a price of $22.15 per share. As a result of the transaction, Bair Teresa Brophy now holds 68,979 shares, worth roughly $1.1 million.

UBS initiated its Kura Oncology Inc [KURA] rating to a Buy in a research note published on October 24, 2024; the price target was $27. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. Mizuho began covering KURA with “Buy” recommendation on December 22, 2023. BofA Securities started covering the stock on August 11, 2023. It rated KURA as “a Buy”.

Price Performance Review of KURA

On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock fall -0.50% to $15.96. Over the last five days, the stock has lost -14.05%. Kura Oncology Inc shares have risen nearly 10.99% since the year began. Nevertheless, the stocks have risen 66.95% over the past one year. While a 52-week high of $24.17 was reached on 03/11/24, a 52-week low of $9.06 was recorded on 01/23/24. SMA at 50 days reached $18.36, while 200 days put it at $20.06.

Levels Of Support And Resistance For KURA Stock

The 24-hour chart illustrates a support level at 15.68, which if violated will result in even more drops to 15.39. On the upside, there is a resistance level at 16.43. A further resistance level may holdings at 16.89. The Relative Strength Index (RSI) on the 14-day chart is 35.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.19%. Stochastics %K at 10.13% indicates the stock is a buying.

How much short interest is there in Kura Oncology Inc?

A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2024-10-31, growing by 0.61 million shares to a total of 10.8 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 10.19 million shares. There was a rise of 5.67%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on July 27, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $10.50 price target.

Most Popular